AUDRA BLOOD

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care DANBURY, CT NPI 1992299036

General Payments — all program years on this page

$386.20

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 20
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $364.83 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $349.9818
Education $14.851

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Gilead Sciences, Inc. $168.3410
ViiV Healthcare Company $134.076
Alkermes, Inc. $33.482
ABBVIE INC. $28.941

By program year

Program yearAmountRecords
2023 $21.371
2024 $364.8319

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1106778239 ABBVIE INC. $28.94 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112705554 ViiV Healthcare Company $34.28 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112712318 ViiV Healthcare Company $7.35 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112765564 ViiV Healthcare Company $11.14 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112784860 ViiV Healthcare Company $29.09 05/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112795698 ViiV Healthcare Company $24.30 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112799976 ViiV Healthcare Company $27.91 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120468345 Alkermes, Inc. $14.85 04/02/2024 Education Undisputed 01/23/2026 View at CMS
1120468347 Alkermes, Inc. $18.63 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702576 Gilead Sciences, Inc. $33.87 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702578 Gilead Sciences, Inc. $7.20 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702580 Gilead Sciences, Inc. $16.45 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702582 Gilead Sciences, Inc. $24.81 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702584 Gilead Sciences, Inc. $8.63 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702586 Gilead Sciences, Inc. $15.92 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702588 Gilead Sciences, Inc. $20.32 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702590 Gilead Sciences, Inc. $31.60 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702592 Gilead Sciences, Inc. $2.86 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133702594 Gilead Sciences, Inc. $6.68 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.